Stock Analysts’ upgrades for Wednesday, August 30th:
Allergy Therapeuti (NASDAQ:AGYTF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Allergy Therapeutics Plc is a specialty pharmaceutical company focused on allergy vaccination. The company’s product pipeline consists of PollinexTrees(R), Pollinex Grasses + Rye(R), Skin Prick Testing, Diagnostic Products and Service. Allergy Therapeutics Plc is based in Worthing, the United Kingdom. “
Absolute Software (NASDAQ:ALSWF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $6.50 target price on the stock. According to Zacks, “Absolute Software Corporation engages in the business of providing firmware-persistent endpoint security and management solutions. It provides solutions for computer security monitoring and endpoint management industry. The company’s solutions include data protection, lifecycle management, enterprise mobility management and IT service management as well as data loss prevention. Absolute Software Corporation is headquartered in Vancouver, Canada. “
Algonquin Power & Utilities Corp. (NYSE:AQN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $12.00 target price on the stock. According to Zacks, “Algonquin Power & Utilities Corp. is a renewable energy and regulated utility company engaged in the ownership of power generation facilities, and water and energy utilities primarily in North America. The Corporation invests in hydroelectric, wind and solar power facilities, and sustainable utility distribution businesses (water, electricity and natural gas) through its subsidiaries. Algonquin Power & Utilities Corp. is headquartered in Oakville, Canada. “
Aradigm Corporation (NASDAQ:ARDM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.50 price target on the stock. According to Zacks, “Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung. “
Amerisur Resources (NASDAQ:ASUXF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Amerisur Resources PLC is an oil and gas exploration and production company. Its primarily portfolio of assets consists in Colombia and Paraguay. Amerisur Resources PLC is headquartered in Wales, Great Britain. “
Alteryx (NYSE:AYX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $26.00 price target on the stock. According to Zacks, “Alteryx, Inc. provides self-service data analytics software platform. The Company’s product consists of Alteryx Designer, Alteryx Server and Alteryx Analytics Gallery. Alteryx Designer offer data preparation, blending and analytics which could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable product for sharing and running analytic applications in a Web-based environment and Alteryx Analytics Gallery, a cloud-based collaboration offering which allows users to share workflows in a centralized repository. Alteryx, Inc. is headquartered in Irvine, California. “
Bitauto Holdings Limited (NYSE:BITA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bitauto Holdings Limited is engaged in providing internet content and marketing services for automotive industry in China. Its bitauto.com and ucar.cn websites provide consumers new and used automobile pricing information, specifications, reviews and consumer feedback. The Company operates in three segments- bitauto.com business, ucar.cn business and digital marketing solutions business. Bitauto.com business provides subscription services to new automobile dealers and advertising services to dealers and automakers on bitauto.com website. Bitauto’s ucar.cn business provides listing and advertising services to used automobile dealers on ucar.cn website. The Company’s digital marketing solutions business provides automakers with digital marketing solutions, including website creation and maintenance, online public relations, online marketing campaigns and advertising agent services. Bitauto Holdings Limited is headquartered in Beijing, the People’s Republic of China. “
Cara Therapeutics (NASDAQ:CARA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $14.00 price target on the stock. According to Zacks, “Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States. “
Cabot Microelectronics Corporation (NASDAQ:CCMP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Cabot Microelectronics Corp. is a leading supplier of slurries used in chemical mechanical planarization, a polishing process used in the manufacturing of integrated circuit devices. Chemical mechanical planarization is an important part of the integrated circuit device manufacturing process because it helps manufacturers make smaller, faster and more complex integrated circuit devices. Chemical mechanical planarization slurries are liquids containing abrasives and chemicals that facilitate and enhance the mechanical planarization polishing process. “
Dycom Industries (NYSE:DY) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. The firm currently has $87.00 price target on the stock.
Zumiez (NASDAQ:ZUMZ) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $15.00 target price on the stock. According to Zacks, “Zumiez has outperformed the industry in the last three months, mainly backed the favorable comps and sales trend in recent months. Notably, the company delivered comps and sales growth for July, which marked the fifth straight month of comps growth. However, the company continues to battle soft mall traffic, volatile consumer spending and macroeconomic volatility. Further, retail industry is challenged by strong U.S. dollar, volatile commodity costs and global uncertainty. Nevertheless, we commend Zumiez’s efforts to keep pace with the evolving retail trends, as evident from its focus on omni-channel development. This helped Zumiez post seventh straight quarter of earnings surprise in first-quarter fiscal 2017. Also, its strategic initiatives, authentic lifestyle positioning and commitment to customer service position it for market share gains in the long term. Estimates have witnessed positive revisions ahead of the second quarter earnings.”
